A public health expert explains how GLP-1 drugs have changed the way healthcare providers understand and treat obesity.

The AACE consensus statement emphasizes improvement of overall health in addition to weight reduction among adults with obesity and adiposity-based chronic disease.

They are nonnegotiable for keeping pounds off long-term.

By 2030, nearly half of all American adults will have obesity, according to research published in the New England Journal of Medicine. In every single state, researchers expect at least 35% of adults ...

Researchers develop a new patient-reported outcome measure that may help assess how obesity or overweight, and their ...

Experts at a roundtable in Boston, Massachusetts, on November 19, 2025, discussed multidisciplinary strategies for obesity ...

The MarketWatch News Department was not involved in the creation of this content. Centennial, Colorado--(Newsfile Corp. - December 24, 2025) - The Obesity Medicine Association (OMA) released its ...

9amHealth, a virtual cardiometabolic care company, and Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs), are collaborating to allow 9amHealth to use lower-cost oral meds from Cost Plus Drugs ...

Researchers are applying insights into the genetic variations and physiology of obesity to apply tailored interventions to ...

Just over one in 10 deaths from a wide range of infectious diseases can be attributed to obesity worldwide, finds a major new ...